完善机制引导长期资金愿投敢投

Group 1 - The core viewpoint emphasizes the need for patient capital to support the commercialization of technological innovation, which faces challenges such as long cycles, high investment, and high risks [1] - Developed countries like the US and Europe have established relatively mature patient capital supply systems through policy guidance and market mechanism innovation, providing valuable lessons [1][3] - The US government has set up venture capital guidance funds to attract private capital into early-stage tech startups, significantly impacting job creation and economic growth [1][2] Group 2 - Various measures have been taken to expand the sources of patient capital, including reforms to pension fund systems and favorable tax regulations to encourage long-term investments in venture capital [2] - The US has seen a substantial reduction in tax rates for venture capital, with the total tax rate dropping from 49% to 20%, stimulating the growth of venture capital [2] - In the UK, the 2017 Pension Reform Act allows pension funds to invest in high-risk assets, including venture capital, enhancing the flow of long-term capital into the market [2] Group 3 - Establishing a comprehensive entrepreneurial innovation ecosystem is crucial for enhancing the success rate of startups, with Silicon Valley serving as a prime example due to its conducive environment for transforming entrepreneurial spirit into technological innovation [3] - High-level research universities play a vital role in foundational research, exemplified by Stanford University’s model of collaboration with industry, leading to the creation of numerous companies [3] Group 4 - Promoting a patient capital mindset involves educating investors about the long-term value of investments and enhancing their professional capabilities in risk assessment and investment management [4] - A robust institutional environment is necessary for the development of patient capital, including improved evaluation systems and mechanisms to support long-term investments [4] Group 5 - Creating a favorable ecosystem for patient capital development requires stable and predictable policy support, as well as a market-oriented and legal environment [5] - Many attempts to replicate Silicon Valley's success have failed due to a limited understanding of its operational model, highlighting the importance of stable policies for fostering patient capital [5]